TriMas (NASDAQ:TRS) Earns Buy Rating from BWS Financial

TriMas (NASDAQ:TRS)‘s stock had its “buy” rating reaffirmed by investment analysts at BWS Financial in a report released on Wednesday, Benzinga reports. They currently have a $40.00 target price on the industrial products company’s stock. BWS Financial’s target price would indicate a potential upside of 64.88% from the stock’s current price.

TriMas Trading Down 4.4 %

TRS traded down $1.12 during trading on Wednesday, hitting $24.26. The company’s stock had a trading volume of 75,266 shares, compared to its average volume of 213,012. TriMas has a twelve month low of $22.59 and a twelve month high of $27.89. The firm’s 50 day moving average price is $26.15 and its 200-day moving average price is $25.76. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.73 and a quick ratio of 1.41. The stock has a market cap of $988.11 million, a PE ratio of 25.01 and a beta of 0.67.

TriMas (NASDAQ:TRS) last issued its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.10). TriMas had a return on equity of 9.68% and a net margin of 4.48%. The business had revenue of $240.50 million during the quarter, compared to analyst estimates of $238.63 million. During the same period in the previous year, the business posted $0.50 earnings per share. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. On average, analysts expect that TriMas will post 2.03 earnings per share for the current year.

Insider Transactions at TriMas

In other news, Director Herbert K. Parker purchased 6,100 shares of the company’s stock in a transaction on Monday, May 6th. The stock was bought at an average cost of $26.52 per share, for a total transaction of $161,772.00. Following the completion of the purchase, the director now directly owns 39,157 shares of the company’s stock, valued at approximately $1,038,443.64. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Herbert K. Parker bought 6,100 shares of the stock in a transaction dated Monday, May 6th. The stock was acquired at an average price of $26.52 per share, for a total transaction of $161,772.00. Following the completion of the purchase, the director now owns 39,157 shares in the company, valued at $1,038,443.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Scott A. Mell sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $27.30, for a total value of $40,950.00. Following the completion of the transaction, the chief financial officer now owns 31,923 shares of the company’s stock, valued at approximately $871,497.90. The disclosure for this sale can be found here. Insiders bought a total of 13,681 shares of company stock worth $361,073 in the last ninety days. Insiders own 1.10% of the company’s stock.

Hedge Funds Weigh In On TriMas

Several institutional investors and hedge funds have recently made changes to their positions in TRS. Quantbot Technologies LP raised its holdings in TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after acquiring an additional 478 shares in the last quarter. Summit Trail Advisors LLC increased its holdings in TriMas by 5.0% in the fourth quarter. Summit Trail Advisors LLC now owns 15,158 shares of the industrial products company’s stock valued at $384,000 after buying an additional 716 shares during the last quarter. Innealta Capital LLC bought a new position in TriMas during the 2nd quarter worth approximately $26,000. Diversified Trust Co lifted its holdings in TriMas by 5.0% during the 2nd quarter. Diversified Trust Co now owns 22,719 shares of the industrial products company’s stock worth $581,000 after buying an additional 1,072 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its stake in TriMas by 6.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company’s stock worth $639,000 after purchasing an additional 1,478 shares during the last quarter. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.